Nanosonics Limited

ASX (AUD): Nanosonics Limited (NAN)

Last Price

3.54

Today's Change

+0.06 (1.72%)

Day's Change

3.47 - 3.57

Trading Volume

400,083

Profile
NAN

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Michael C. Kavanagh BSc, M.B.A. Mr. Michael C. Kavanagh BSc, M.B.A.

Full Time Employees:  466 466

IPO Date:  2007-05-17 2007-05-17

CIK: 

ISIN:  AU000000NAN9 AU000000NAN9

CUSIP:  Q6499K102 Q6499K102

Beta:  1.55 1.55

Last Dividend:  0.00 0.00

Dcf Diff:  1.71 1.71

Dcf:  1.77 1.77

Description

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Address

Building A,
Macquarie Park, NSW 2113, AU

61 2 8063 1600

http://www.nanosonics.com.au

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment